BioSpace News Archive

Deals

Fuse Medical, Inc. Completes Acquisition of CPM Medical Consultants, LLC

The effective date of closing was December 31, 2017.

January 5, 2018
·
2 min read
Drug Development

Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies

The Company reports the initiation of the AdAPT Study (Adenovirus after Allogeneic Pediatric Transplantation).

January 5, 2018
·
7 min read
Festival of Genomics London 2018: the Landmark Event Making Genomics Mainstream

This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK.

January 5, 2018
·
2 min read
Drug Development

Avelas Biosciences Completes Period 1 Patient Enrollment in Phase II Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Period 1 was designed to enroll approximately 30 patients to evaluate optimal conditions to achieve differences in fluorescent signals between malignant and nonmalignant tissues.

January 5, 2018
·
2 min read
Business

Global medtech firm SciCan deepens commitment to domestic manufacturing with 8,000 square foot expansion of Toronto facility

SciCan, a Canadian manufacturer of dental and medical technology, completed the expansion of its warehouse this fall, adding 8,000 square feet to its Don Mills manufacturing facility and signalling the continued growth of international demand for Canadian medical exports.

January 5, 2018
·
2 min read
Pharm Country

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635

The awards were made pursuant to the NASDAQ inducement grant exception as a component of the new hires’ employment compensation.

January 5, 2018
·
2 min read
Business

Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

Distributed Bio announce an agreement with Pfizer Inc. to license the Distributed Bio SuperHuman Platform for the identification of novel antibodies for use as therapeutic agents.

January 5, 2018
·
3 min read
Business

Datavant and Verge Genomics Forge Strategic Alliance to Accelerate Drug Development

Datavant and Verge Genomics today announced a strategic alliance to unlock the value of pharmaceutical datasets to accelerate drug discovery and development.

January 5, 2018
·
3 min read